Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2009-06-30
2011-11-29
Ouspenski, Ilia (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reexamination Certificate
active
08066992
ABSTRACT:
A medicament based on antibodies contains an activated form of monoclonal, polyclonal, or natural antibodies to interferon in low or ultra-low doses prepared by multiple consecutive dilutions and exposure to external factors, preferably in accordance with homeopathic technology. In order to obtain antibodies, human or heterologous interferon alpha, beta, or gamma, including recombinant interferon, is used; a mixture of various, mostly centimal, homeopathic dilutions being employed. A method of treating a pathologic syndrome, whose formation is affected by interferon, consists in the use of activated forms of antibodies to interferon alpha, beta, or gamma in low or ultra-low doses obtained by multiple consecutive dilutions and exposure to external factors.
REFERENCES:
patent: 4963367 (1990-10-01), Ecanow
patent: 4987127 (1991-01-01), Sirany
patent: 5629286 (1997-05-01), Brewitt
patent: 5683712 (1997-11-01), Cavazza
patent: 5698195 (1997-12-01), Le et al.
patent: 6136309 (2000-10-01), Novick et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 7087726 (2006-08-01), Chuntharapai et al.
patent: 7572441 (2009-08-01), Epshtein et al.
patent: 7582294 (2009-09-01), Epshtein et al.
patent: 2003/0099636 (2003-05-01), Epshtein et al.
patent: 2006/0165697 (2006-07-01), Epshtein et al.
patent: 2007/0123518 (2007-05-01), Epshtein
patent: 2007/0141058 (2007-06-01), Iliich et al.
patent: 0652014 (1995-05-01), None
patent: 0687466 (1995-12-01), None
patent: 2007989 (1994-02-01), None
patent: 2033784 (1995-04-01), None
patent: 2104032 (1998-02-01), None
patent: 2122858 (1998-12-01), None
patent: 2137483 (1999-09-01), None
patent: 2144370 (2000-01-01), None
patent: 98109384 (2000-03-01), None
patent: 1730144 (1992-04-01), None
patent: 9412213 (1994-06-01), None
patent: 9422846 (1994-10-01), None
patent: 0105371 (2001-01-01), None
patent: 03055518 (2003-07-01), None
patent: 03037372 (2003-08-01), None
patent: 03077946 (2003-09-01), None
patent: 2008097132 (2008-08-01), None
patent: 2008097133 (2008-08-01), None
Alexandrova et al., “An Experience of Application of Potentiated Compounds for Jugulation of Alcohol Abstinent Syndrome and Opiate Abstinent Syndrome,” Bull of Siberian Branch of RAMS, No. 1 (91), 1999.
Beregovoy et al., On influence of various Dilutions of Monoclonal Antibodies 5F5-B6 on the Formation of Long-Term Post-Tetanic Potentiation in Survived Hippocampal Slices, Bull of Siberian Branch of RAMS No. 1 (91), 1999.
Davenas et al., Nature, 1988, 333: 816-818.
Epshtein et al. May 1999, Bulletin of Experimental Biology and Medicine,vol. 5: 493-495.
Frimel, G., ed., “Immunological Methods,” Medicina Publishing House, 1987, pp. 9-33.
Gaevy, M.D. et al., “Osnovy klinicheskoi farmakologii I farmakoterapii,” Moscow, Aliyans-B, 2002, pp. 42-44.
Goldacre (2007) Lancet 370: 1672-1673.
Grigoriev M. Yu. et al., “K probleme ispolzovaniya potentsirovannykh organnykh preparatov, ” Lechebno-profilakticheskaja Rabota Dlya Meditsinskikh Organizatsij V Ugolnoj Promyshlennosti, vyp. 8, 1989, izd. Tsniehi ugol (Moscow), pp. 163-165.
International Search Report from International Application No. PCT/RU02/00367, filed Aug. 2, 2002, mailed on Dec. 19, 2002.
International Search Report from International Application No. PCT/RU01/00239, filed Jun. 19, 2001, mailed on Sep. 20, 2001.
International Search Report from International Application No. PCT/RU02/00365, filed Aug. 2, 2002, mailed on Dec. 5, 2002.
International Search Report from International Application No. PCT/RU02/00368, filed Aug. 2, 2002, mailed on Dec. 5, 2002.
International Search Report from International Application No. PCT/RU02/00369, filed Aug. 2, 2002, mailed on Dec. 19, 2002.
International Search Report from International Application No. PCT/RU97/00026, filed Feb. 10, 1997, mailed on Apr. 8, 1997.
Ivaniushkin, A. Ja., “Gomeopatiya i sovremennaya meditsina,” Vestnik Akademii Meditsinskikh Nauk SSSR, 4, 1988, izd. “Meditsina” (Moscow), pp. 76-82.
Janeway et al. Immunobiology, 1997, 3rd edition, Garland Publishing Inc., pp. 3:1-3:11.
Jeger, J., Ed., “Clinical Immunology and Allergology” (Russian Translation), Meditsina, Moscow, 2000, pp. 358-359.
Kuznik, R.I. et al., “Cytomedines and their Role in Regulation of Physiological Functions,” Uspekhi Sovremennoi Biologii, 1995, vol. 115, No. 3, pp. 353-367.
Linde et al., 1997, Lancet, vol. 350: 834-43.
Maini, R. N. et al., “Anti-Cytokine Therapy for Rheumatoid Arthritis,” Annu, Rev. Med., 2000; 51: 207-229.
Palace et al., 2003, J. Neur. Sci. vol. 206: 131-134.
Register of Pharmaceuticals of Russia, Encyclopedia of Pharmaceuticals (in Russian), Moscow, 2000, pp. 358-359.
Register of Pharmaceuticals of Russia, Encyclopedia of Pharmaceuticals (in Russian), Moscow, 2001, pp. 788-789.
Schwab, V., “Homeopathic Pharmaceutical Agents. A manual on description and preparation,” Moscow, 1967, pp. 12-38.
Shang et al., 2005, Lancet, vol. 366: 726-32.
Skurkovich, et al. Multiple Sclerosis 7:277-284, 2001 “Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis.”
Stefani, D. V. et al., “Immunologiya i immunopatologiya detskogo vozrasta,” Moscow, Meditsina, 1996, pp. 28, 29, 358-359.
Vasiliev, Yu, V. et al., “Gomeopatiya: vozrozhdenie traditsionnioy meditsinskoj shkoly,” Vestnik Rossijkoj Akademii Nauk, 10, 1992, izd. “Nauka” (Moscow), pp. 145-148.
Vyazov, O.L., Laboratory Methods of Studies in Non-Infection Immunology (in Russian)m Moscow, Meditsina, 1968.
Schwabe, W., “German Homeopathic pharmacopoeia (Homeopathisches Arzneibuch),” Stuttgart, Translation of the 5th Supplement (1991) to the 1978 edition.
Gilman Pergament LLP
Ouspenski Ilia
LandOfFree
Medicament and a method of treating a pathological syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament and a method of treating a pathological syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament and a method of treating a pathological syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301766